Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 7/20 | 0.46 |
| ▸ | LCK | P06239 | 7/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.41 |
| ▸ | EGFR | P00533 | 5/20 | 0.41 |
| ▸ | JAK3 | P52333 | 5/20 | 0.41 |
| ▸ | ACP1 | P24666 | 2/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1705889 | 0.92 | BTK (0.44) | BTKLCKLRRK2EGFRJAK3 | |
| SCHEMBL1705199 | 0.82 | BTK (0.49) | BTKLCKEGFRJAK3ACP1 | |
| SCHEMBL10169544 | 0.79 | LRRK2 (0.47) | BTKLCKLRRK2EGFRJAK3 | |
| SCHEMBL893873 | 0.79 | LRRK2 (0.47) | BTKLCKLRRK2JAK3SYK | |
| SCHEMBL1705032 | 0.78 | BTK (0.56) | BTKLCKEGFRJAK3SYK | |
| SCHEMBL893939 | 0.77 | BTK (0.53) | BTKLCKEGFRJAK3 | |
| SCHEMBL893937 | 0.77 | BTK (0.53) | BTKLCKEGFRJAK3 | |
| SCHEMBL894824 | 0.76 | LCK (0.58) | BTKLCKEGFRJAK3 | |
| SCHEMBL1704943 | 0.75 | BTK (0.49) | BTKLCKLRRK2EGFRJAK3 | |
| SCHEMBL1704941 | 0.75 | BTK (0.49) | BTKLCKLRRK2EGFRJAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2440204-A1 | NICOTINAMIDE COMPOUNDS USEFUL AS KINASE MODULATORS | Bristol-Myers Squibb Company (US) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010144647-A1 | NICOTINAMIDE COMPOUNDS USEFUL AS KINASE MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-12-16 | — | — | WO | disclosed |